Login

Mangold Insight interviews tech company DLTx, delving into discussions on AI competitiveness with a reference to C3.ai. 00:10:00

Share On Facebook Share On Twitter

DLTx's founder is Timothy Furey.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
American Creek Resources: Breakthrough Resource Estimate at Treaty Creek
00:10:00
Navigating the Impact of AI on Enterprise Investments and Market Dynamics | Jennifer Tejada, CEO, PagerDuty Inc.
00:10:00
Candente Copper Focuses on Lowering Capex and Improving ESG in Cajamarquilla Norte Copper Project
00:10:00
Engaging Yukoners in Shaping the Future Through Financial Planning
00:10:00
Banyan Gold's Tara Christie on Advancing Yukon's Ormac Project and 2022 Plans
00:10:00
Understanding In-Kind Support and Maintenance (ISM) and Its Impact on SSI Benefits | Mike Walther, President , Oak Wealth Advisors LLC.
00:10:00
We have enough renewable energy at our disposal to power the world|Agate Freimane,General Partner,Norrsken VC
00:10:00
Allspring’s vision is to inspire a new era of investing that pursues both financial returns and positive outcomes. Diverse perspectives power our investment strategies through a unified platform and a commitment to our clients.| Joe Sullivan,Chief Executi
00:00:00
Amir R. Khan, M.D. Ophthalmologist, Mayo Clinic
00:10:00
Paul Townsend on Family Law: Impact, Energy, and Pro Tips for Choosing the Right Attorney
00:10:00
Sebastian Junger on War: Fear, Terrain, and the Human Spirit
00:10:00
April 2015 Economic Update: Earnings, GDP, and Fed Insights

© 2026 Nehu